HUWE1 Is a Molecular Link Controlling RAF-1 Activity Supported by the Shoc2 Scaffold

REFERENCES

• Katz M, Amit I, Yarden Y. 2007. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim. Biophys. Acta 1773:1161–1176. http://dx.doi.org/10.1016/j.bbamcr.2007.01.002.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya RP, Remenyi A, Yeh BJ, Lim WA. 2006. Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu. Rev. Biochem. 75:655–680. http://dx.doi.org/10.1146/annurev.biochem.75.103004.142710.
   PubMed Web of Science ®Google Scholar
• Witzel F, Maddison L, Bluthgen N. 2012. How scaffolds shape MAPK signaling: what we know and opportunities for systems approaches. Front. Physiol. 3:475. http://dx.doi.org/10.3389/fphys.2012.00475.
   PubMedGoogle Scholar
• Pullikuth AK, Catling AD. 2007. Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell. Signal. 19:1621–1632. http://dx.doi.org/10.1016/j.cellsig.2007.04.012.
   PubMed Web of Science ®Google Scholar
• Brown MD, Sacks DB. 2008. Compartmentalised MAPK pathways. Handb. Exp. Pharmacol. 186:205–235. http://dx.doi.org/10.1007/978-3-540-72843-6_9.
   Google Scholar
• Brown MD, Sacks DB. 2009. Protein scaffolds in MAP kinase signalling. Cell. Signal. 21:462–469. http://dx.doi.org/10.1016/j.cellsig.2008.11.013.
   PubMed Web of Science ®Google Scholar
• Good MC, Zalatan JG, Lim WA. 2011. Scaffold proteins: hubs for controlling the flow of cellular information. Science 332:680–686. http://dx.doi.org/10.1126/science.1198701.
   PubMed Web of Science ®Google Scholar
• Sieburth DS, Sun Q, Han M. 1998. SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 94:119–130. http://dx.doi.org/10.1016/S0092-8674(00)81227-1.
   PubMed Web of Science ®Google Scholar
• Selfors LM, Schutzman JL, Borland CZ, Stern MJ. 1998. soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 95:6903–6908. http://dx.doi.org/10.1073/pnas.95.12.6903.
   PubMed Web of Science ®Google Scholar
• Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, Fodale V, Cecchetti S, Cardinale A, Martin J, Schackwitz W, Lipzen A, Zampino G, Mazzanti L, Digilio MC, Martinelli S, Flex E, Lepri F, Bartholdi D, Kutsche K, Ferrero GB, Anichini C, Selicorni A, Rossi C, Tenconi R, Zenker M, Merlo D, Dallapiccola B, Iyengar R, Bazzicalupo P, Gelb BD, Tartaglia M. 2009. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat. Genet. 41:1022–1026. http://dx.doi.org/10.1038/ng.425.
   PubMed Web of Science ®Google Scholar
• Yi J, Chen M, Wu X, Yang X, Xu T, Zhuang Y, Han M, Xu R. 2010. Endothelial SUR-8 acts in an ERK-independent pathway during atrioventricular cushion development. Dev. Dyn. 239:2005–2013. http://dx.doi.org/10.1002/dvdy.22343.
   PubMed Web of Science ®Google Scholar
• Li W, Han M, Guan KL. 2000. The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev. 14:895–900.
   PubMed Web of Science ®Google Scholar
• Galperin E, Abdelmoti L, Sorkin A. 2012. Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells. PLoS One 7:e36469. http://dx.doi.org/10.1371/journal.pone.0036469.
   PubMedGoogle Scholar
• Matsunaga-Udagawa R, Fujita Y, Yoshiki S, Terai K, Kamioka Y, Kiyokawa E, Yugi K, Aoki K, Matsuda M. 2010. The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf. J. Biol. Chem. 285:7818–7826. http://dx.doi.org/10.1074/jbc.M109.053975.
   PubMed Web of Science ®Google Scholar
• Yoshiki S, Matsunaga-Udagawa R, Aoki K, Kamioka Y, Kiyokawa E, Matsuda M. 2010. Ras and calcium signaling pathways converge at Raf1 via the Shoc2 scaffold protein. Mol. Biol. Cell 21:1088–1096. http://dx.doi.org/10.1091/mbc.E09-06-0455.
   PubMedGoogle Scholar
• de Bie P, Ciechanover A. 2011. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death Differ. 18:1393–1402. http://dx.doi.org/10.1038/cdd.2011.16.
   PubMed Web of Science ®Google Scholar
• Hoeller D, Hecker CM, Dikic I. 2006. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 6:776–788. http://dx.doi.org/10.1038/nrc1994.
   PubMed Web of Science ®Google Scholar
• Kirkin V, Dikic I. 2007. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr. Opin. Cell Biol. 19:199–205. http://dx.doi.org/10.1016/j.ceb.2007.02.002.
   PubMed Web of Science ®Google Scholar
• MacGurn JA, Hsu PC, Emr SD. 2012. Ubiquitin and membrane protein turnover: from cradle to grave. Annu. Rev. Biochem. 81:231–259. http://dx.doi.org/10.1146/annurev-biochem-060210-093619.
   PubMed Web of Science ®Google Scholar
• Marchese A, Trejo J. 2013. Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling. Cell. Signal. 25:707–716. http://dx.doi.org/10.1016/j.cellsig.2012.11.024.
   PubMedGoogle Scholar
• Grabbe C, Husnjak K, Dikic I. 2011. The spatial and temporal organization of ubiquitin networks. Nat. Rev. Mol. Cell Biol. 12:295–307. http://dx.doi.org/10.1038/nrm3099.
   PubMed Web of Science ®Google Scholar
• Clark K, Nanda S, Cohen P. 2013. Molecular control of the NEMO family of ubiquitin-binding proteins. Nat. Rev. Mol. Cell Biol. 14:673–685. http://dx.doi.org/10.1038/nrm3644.
   PubMed Web of Science ®Google Scholar
• Pervin S, Tran A, Tran L, Urman R, Braga M, Chaudhuri G, Singh R. 2011. Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells. Br. J. Cancer 105:428–437. http://dx.doi.org/10.1038/bjc.2011.242.
   PubMedGoogle Scholar
• Shmueli A, Oren M. 2005. Life, death, and ubiquitin: taming the mule. Cell 121:963–965. http://dx.doi.org/10.1016/j.cell.2005.06.018.
   PubMed Web of Science ®Google Scholar
• Zhong Q, Gao W, Du F, Wang X. 2005. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121:1085–1095. http://dx.doi.org/10.1016/j.cell.2005.06.009.
   PubMed Web of Science ®Google Scholar
• Bernassola F, Karin M, Ciechanover A, Melino G. 2008. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14:10–21. http://dx.doi.org/10.1016/j.ccr.2008.06.001.
   PubMed Web of Science ®Google Scholar
• Chen D, Brooks CL, Gu W. 2006. ARF-BP1 as a potential therapeutic target. Br. J. Cancer 94:1555–1558. http://dx.doi.org/10.1038/sj.bjc.6603119.
   PubMed Web of Science ®Google Scholar
• Confalonieri S, Quarto M, Goisis G, Nuciforo P, Donzelli M, Jodice G, Pelosi G, Viale G, Pece S, Di Fiore PP. 2009. Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene 28:2959–2968. http://dx.doi.org/10.1038/onc.2009.156.
   PubMed Web of Science ®Google Scholar
• Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, Kogel U, Scheffner M, Helin K, Eilers M. 2005. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123:409–421. http://dx.doi.org/10.1016/j.cell.2005.08.016.
   PubMed Web of Science ®Google Scholar
• Zhang X, Berger FG, Yang J, Lu X. 2011. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. EMBO J. 30:2177–2189. http://dx.doi.org/10.1038/emboj.2011.125.
   PubMed Web of Science ®Google Scholar
• Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F, Iavarone A, Lasorella A. 2008. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat. Cell Biol. 10:643–653. http://dx.doi.org/10.1038/ncb1727.
   PubMed Web of Science ®Google Scholar
• Nava C, Lamari F, Heron D, Mignot C, Rastetter A, Keren B, Cohen D, Faudet A, Bouteiller D, Gilleron M, Jacquette A, Whalen S, Afenjar A, Perisse D, Laurent C, Dupuits C, Gautier C, Gerard M, Huguet G, Caillet S, Leheup B, Leboyer M, Gillberg C, Delorme R, Bourgeron T, Brice A, Depienne C. 2012. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl. Psychiatry 2:e179. http://dx.doi.org/10.1038/tp.2012.102.
   PubMedGoogle Scholar
• Froyen G, Corbett M, Vandewalle J, Jarvela I, Lawrence O, Meldrum C, Bauters M, Govaerts K, Vandeleur L, Van Esch H, Chelly J, Sanlaville D, van Bokhoven H, Ropers HH, Laumonnier F, Ranieri E, Schwartz CE, Abidi F, Tarpey PS, Futreal PA, Whibley A, Raymond FL, Stratton MR, Fryns JP, Scott R, Peippo M, Sipponen M, Partington M, Mowat D, Field M, Hackett A, Marynen P, Turner G, Gecz J. 2008. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am. J. Hum. Genet. 82:432–443. http://dx.doi.org/10.1016/j.ajhg.2007.11.002.
   PubMed Web of Science ®Google Scholar
• Galperin E, Sorkin A. 2005. Visualization of Rab5 activity in living cells using FRET microscopy. Methods Enzymol. 403:119–134. http://dx.doi.org/10.1016/S0076-6879(05)03011-9.
   PubMedGoogle Scholar
• Galperin E, Sorkin A. 2008. Endosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosis. Traffic 9:1776–1790. http://dx.doi.org/10.1111/j.1600-0854.2008.00788.x.
   PubMedGoogle Scholar
• Hall JR, Kow E, Nevis KR, Lu CK, Luce KS, Zhong Q, Cook JG. 2007. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol. Biol. Cell 18:3340–3350. http://dx.doi.org/10.1091/mbc.E07-02-0173.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101–1108. http://dx.doi.org/10.1038/nprot.2008.73.
   PubMed Web of Science ®Google Scholar
• Sorkin A, Duex JE. 2010. Quantitative analysis of endocytosis and turnover of epidermal growth factor (EGF) and EGF receptor. Curr. Protoc. Cell Biol. Chapter 15:Unit 15.14. http://dx.doi.org/10.1002/0471143030.cb1514s46.
   Google Scholar
• Jiang X, Sorkin A. 2003. Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic 4:529–543. http://dx.doi.org/10.1034/j.1600-0854.2003.t01-1-00109.x.
   PubMedGoogle Scholar
• Cheng A, Zhang M, Gentry MS, Worby CA, Dixon JE, Saltiel AR. 2007. A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease. Genes Dev. 21:2399–2409. http://dx.doi.org/10.1101/gad.1553207.
   PubMedGoogle Scholar
• Jeoung M, Abdelmoti L, Jang ER, Vander Kooi CW, Galperin E. 2013. Functional integration of the conserved domains of Shoc2 scaffold. PLoS One 8:e66067. http://dx.doi.org/10.1371/journal.pone.0066067.
   PubMedGoogle Scholar
• Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. 2006. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol. Cell 22:217–230. http://dx.doi.org/10.1016/j.molcel.2006.03.027.
   PubMed Web of Science ®Google Scholar
• Jeoung M, Galperin E. 2014. Visualizing of signaling proteins on endosomes utilizing knockdown and reconstitution approach. Methods Enzymol. 534:47–63. http://dx.doi.org/10.1016/B978-0-12-397926-1.00003-2.
   PubMedGoogle Scholar
• Kurokawa M, Kim J, Geradts J, Matsuura K, Liu L, Ran X, Xia W, Ribar TJ, Henao R, Dewhirst MW, Kim WJ, Lucas JE, Wang S, Spector NL, Kornbluth S. 2013. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53. Sci. Signal. 6:ra32. http://dx.doi.org/10.1126/scisignal.2003741.
   PubMed Web of Science ®Google Scholar
• Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse HCIII. 2012. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms. Int. J. Mol. Sci. 13:6204–6219. http://dx.doi.org/10.3390/ijms13056204.
   PubMedGoogle Scholar
• Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F, Iavarone A, Lasorella A. 2008. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat. Cell Biol. 10:643–653. http://dx.doi.org/10.1038/ncb1727.
   PubMed Web of Science ®Google Scholar
• Dogan T, Harms GS, Hekman M, Karreman C, Oberoi TK, Alnemri ES, Rapp UR, Rajalingam K. 2008. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nat. Cell Biol. 10:1447–1455. http://dx.doi.org/10.1038/ncb1804.
   PubMed Web of Science ®Google Scholar
• Du J, Zeng J, Ou X, Ren X, Cai S. 2006. Methylglyoxal downregulates Raf-1 protein through a ubiquitination-mediated mechanism. Int. J. Biochem. Cell Biol. 38:1084–1091. http://dx.doi.org/10.1016/j.biocel.2005.10.019.
   PubMed Web of Science ®Google Scholar
• Noble C, Mercer K, Hussain J, Carragher L, Giblett S, Hayward R, Patterson C, Marais R, Pritchard CA. 2008. CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation. Mol. Cell 31:862–872. http://dx.doi.org/10.1016/j.molcel.2008.08.026.
   PubMed Web of Science ®Google Scholar
• Pandya RK, Partridge JR, Love KR, Schwartz TU, Ploegh HL. 2010. A structural element within the HUWE1 HECT domain modulates self-ubiquitination and substrate ubiquitination activities. J. Biol. Chem. 285:5664–5673. http://dx.doi.org/10.1074/jbc.M109.051805.
   PubMedGoogle Scholar
• Hurley JH, Lee S, Prag G. 2006. Ubiquitin-binding domains. Biochem. J. 399:361–372. http://dx.doi.org/10.1042/BJ20061138.
   PubMed Web of Science ®Google Scholar
• Inoue S, Hao Z, Elia AJ, Cescon D, Zhou L, Silvester J, Snow B, Harris IS, Sasaki M, Li WY, Itsumi M, Yamamoto K, Ueda T, Dominguez-Brauer C, Gorrini C, Chio II, Haight J, You-Ten A, McCracken S, Wakeham A, Ghazarian D, Penn LJ, Melino G, Mak TW. 2013. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15. Genes Dev. 27:1101–1114. http://dx.doi.org/10.1101/gad.214577.113.
   PubMedGoogle Scholar
• Hurley JH, Stenmark H. 2011. Molecular mechanisms of ubiquitin-dependent membrane traffic. Annu. Rev. Biophys. 40:119–142. http://dx.doi.org/10.1146/annurev-biophys-042910-155404.
   PubMedGoogle Scholar
• Nathan JA, Kim HT, Ting L, Gygi SP, Goldberg AL. 2013. Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? EMBO J. 32:552–565. http://dx.doi.org/10.1038/emboj.2012.354.
   PubMedGoogle Scholar
• Kirkpatrick DS, Denison C, Gygi SP. 2005. Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nat. Cell Biol. 7:750–757. http://dx.doi.org/10.1038/ncb0805-750.
   PubMed Web of Science ®Google Scholar
• Denis NJ, Vasilescu J, Lambert JP, Smith JC, Figeys D. 2007. Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry. Proteomics 7:868–874. http://dx.doi.org/10.1002/pmic.200600410.
   PubMedGoogle Scholar
• Papin C, Denouel-Galy A, Laugier D, Calothy G, Eychene A. 1998. Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J. Biol. Chem. 273:24939–24947. http://dx.doi.org/10.1074/jbc.273.38.24939.
   PubMed Web of Science ®Google Scholar
• Pumiglia KM, Decker SJ. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U. S. A. 94:448–452. http://dx.doi.org/10.1073/pnas.94.2.448.
   PubMed Web of Science ®Google Scholar
• Sewing A, Wiseman B, Lloyd AC, Land H. 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5588–5597.
   PubMed Web of Science ®Google Scholar
• Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598–5611.
   PubMed Web of Science ®Google Scholar
• Young LC, Hartig N, Munoz-Alegre M, Oses-Prieto JA, Durdu S, Bender S, Vijayakumar V, Vietri Rudan M, Gewinner C, Henderson S, Jathoul AP, Ghatrora R, Lythgoe MF, Burlingame AL, Rodriguez-Viciana P. 2013. An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth. Mol. Cell 52:679–692. http://dx.doi.org/10.1016/j.molcel.2013.10.004.
   PubMed Web of Science ®Google Scholar
• Yoon SY, Lee Y, Kim JH, Chung AS, Joo JH, Kim CN, Kim NS, Choe IS, Kim JW. 2005. Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. Biochem. Biophys. Res. Commun. 326:7–17. http://dx.doi.org/10.1016/j.bbrc.2004.11.004.
   PubMed Web of Science ®Google Scholar
• Zhao X, D'Arca D, Lim WK, Brahmachary M, Carro MS, Ludwig T, Cardo CC, Guillemot F, Aldape K, Califano A, Iavarone A, Lasorella A. 2009. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev. Cell 17:210–221. http://dx.doi.org/10.1016/j.devcel.2009.07.009.
   PubMedGoogle Scholar
• de Groot RE, Ganji RS, Bernatik O, Lloyd-Lewis B, Seipel K, Sedova K, Zdrahal Z, Dhople VM, Dale TC, Korswagen HC, Bryja V. 2014. Huwe1-mediated ubiquitylation of dishevelled defines a negative feedback loop in the Wnt signaling pathway. Sci. Signal. 7:ra26. http://dx.doi.org/10.1126/scisignal.2004985.
   PubMedGoogle Scholar
• Gripp KW, Zand DJ, Demmer L, Anderson CE, Dobyns WB, Zackai EH, Denenberg E, Jenny K, Stabley DL, Sol-Church K. 2013. Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis. Am. J. Med. Genet. A 161:2420–2430. http://dx.doi.org/10.1002/ajmg.a.36098.
   Web of Science ®Google Scholar
• Hoban R, Roberts AE, Demmer L, Jethva R, Shephard B. 2012. Noonan syndrome due to a SHOC2 mutation presenting with fetal distress and fatal hypertrophic cardiomyopathy in a premature infant. Am. J. Med. Genet. A 158A:1411–1413. http://dx.doi.org/10.1002/ajmg.a.35318.
   PubMedGoogle Scholar